Devices for Assessment of Thoracic Duct Structure/Function in Central Conducting Lymphatic Anomaly
3DT Holdings, LLC, in San Diego aims to develop a first-in-class interventional device to measure lymphatic flow and obstruction in real time, so clinicians can detect thoracic duct disease and related conditions, such as heart failure, earlier and more accurately, helping prevent years of misdiagnosis and serious complications.